- Home
- DLHC vs ACHV Comparison
DLHC vs ACHV Comparison
Compare DLHC & ACHV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DLHC
- ACHV
- Stock Information
- Founded
- DLHC 1969
- ACHV N/A
- Country
- DLHC United States
- ACHV United States
- Employees
- DLHC N/A
- ACHV N/A
- Industry
- DLHC Business Services
- ACHV Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- DLHC Consumer Discretionary
- ACHV Health Care
- Exchange
- DLHC Nasdaq
- ACHV Nasdaq
- Market Cap
- DLHC 79.6M
- ACHV 72.5M
- IPO Year
- DLHC N/A
- ACHV N/A
- Fundamental
- Price
- DLHC $5.70
- ACHV $2.75
- Analyst Decision
- DLHC
- ACHV Strong Buy
- Analyst Count
- DLHC 0
- ACHV 3
- Target Price
- DLHC N/A
- ACHV $14.33
- AVG Volume (30 Days)
- DLHC 95.5K
- ACHV 1.7M
- Earning Date
- DLHC 07-30-2025
- ACHV 08-12-2025
- Dividend Yield
- DLHC N/A
- ACHV N/A
- EPS Growth
- DLHC 75.08
- ACHV N/A
- EPS
- DLHC 0.38
- ACHV N/A
- Revenue
- DLHC $377,074,000.00
- ACHV N/A
- Revenue This Year
- DLHC N/A
- ACHV N/A
- Revenue Next Year
- DLHC N/A
- ACHV N/A
- P/E Ratio
- DLHC $15.03
- ACHV N/A
- Revenue Growth
- DLHC N/A
- ACHV N/A
- 52 Week Low
- DLHC $2.72
- ACHV $1.84
- 52 Week High
- DLHC $11.99
- ACHV $5.31
- Technical
- Relative Strength Index (RSI)
- DLHC 55.57
- ACHV 49.29
- Support Level
- DLHC $5.60
- ACHV $2.25
- Resistance Level
- DLHC $5.97
- ACHV $2.39
- Average True Range (ATR)
- DLHC 0.20
- ACHV 0.23
- MACD
- DLHC -0.04
- ACHV -0.03
- Stochastic Oscillator
- DLHC 46.77
- ACHV 39.47
About DLHC DLH Holdings Corp.
DLH Holdings Corp is a provider of technology-enabled business process outsourcing and program management solutions in the United States. The company offers services to several government agencies which include the Department of Veteran Affairs. The company is engaged in public health, performance evaluation, and health operations to solve the complex problems faced by civilian and military customers alike, leveraging digital transformation, artificial intelligence, analytics, cloud-based applications, telehealth systems, and others.
About ACHV Achieve Life Sciences Inc.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.